Skip to content
Search
Please enter at least 3 characters.

Latest Stories

RPS England, PDA urge government to publish NHS workforce plan

Royal Pharmaceutical Society (RPS) England and Pharmacists Defence Association (PDA) have joined with professional bodies, trade unions and patient groups to call on the government to publish the NHS Long-Term Workforce Plan.

A joint letter signed by almost 40 organisations raises concerns over ongoing delays to the publication of the workforce plan and urges the Prime Minister to take urgent action to help meet current and future patient needs.


English Pharmacy Board Chair Thorrun Govind said: “The range of health and care leaders backing this letter shows just how important it is that the Government acts now to support our workforce.

“It is vital that we recruit and retain the staff we need so we can keep looking after patients.

“When we met NHS England in January, pharmacy leaders called for the plan to include the whole of pharmacy and to recognise the increasing role of pharmacist independent prescribers in our health service.

“With teams under pressure across the system, this workforce plan also needs to support staff retention, secure protected time for learning and development, and ensure continued access to wellbeing services.”

PDA commented: “The workforce plan was originally earmarked for publication in Spring 2022 but has still not been published. Media speculation suggests that there is a disagreement between the Treasury and Department for Health and Social Care on the scale of the staffing needed for the NHS and other sectors.

Meanwhile pharmacists see first hand the impact on patients from understaffing across the health system.  Understaffing also has an adverse impact on the wellbeing of those staff who are in post.”

The signatories have warned the Government that it will take time to resolve this situation. Every day of delay in committing to action pushes back when patients will see the improvements they deserve.

More For You

RPS Wales calls for urgent investment in pharmacy workforce at Senedd meeting

Third from the left: Eluned Morgan, First Minister of Wales

Photo credit: RPS

Invest in pharmacy workforce: RPS Wales urges Senedd members

Members of the Senedd (MSs) were briefed on the increasing pressures facing pharmacy teams and the urgent need for action to support their health and wellbeing at an event hosted by the Royal Pharmaceutical Society (RPS) Wales.

The event, held on Wednesday, brought together MSs, including first minister Eluned Morgan, to discuss the findings of RPS’ latest Workforce Wellbeing Survey.

Keep ReadingShow less
Imported dengue reach record high, warns UKSHA

Most dengue cases were linked to travel to Southern and South-Eastern Asia.

Getty Images

Imported dengue cases hit record high – Consult your pharmacist before you travel

The UK Health Security Agency (UKSHA) has warned that imported dengue cases in England, Wales, and Northern Ireland (EWNI) have reached their highest level since dengue surveillance began in 2009.

New data from the agency reveals that 904 dengue cases were reported among returning travellers in these countries in 2024, a sharp increase from 631 in 2023.

Keep ReadingShow less
Henry Gregg named as new NPA chief executive

Henry Gregg (left) with Sir Chris Whitty

Pic credit: Henry Gregg/X

Henry Gregg named as new NPA chief executive

The National Pharmacy Association (NPA) has announced Henry Gregg will be the organisation’s new chief executive from May.

Gregg, who is currently director of external affairs at Asthma + Lung UK, replaces Paul Rees who departed in January.

Keep ReadingShow less
Kelso Pharma continues expansion with £140M funding boost

Kelso Pharma will use the funds to support further acquisitions and expand in the UK and Europe.

Getty Images

Kelso Pharma secures over £140m of acquisition funding

Kelso Pharma has secured more than £140 million of acquisition funding to support its expansion in the UK and across Europe.

The specialty pharmaceuticals business today (27) confirmed that a proportion of the funding was used for its acquisition of ALTURiX last month, a deal that doubled the size of the company’s UK business.

Keep ReadingShow less
Community pharmacist accessing GP Connect Access Record on Cegedim Rx platform

GP Connect Access Record will make a patient’s relevant medical information available to pharmacy.

Getty Images

Cegedim Rx activates GP Connect Access Record

Community pharmacy IT supplier Cegedim Rx has made GP Connect Access Record functionality available across its clinical services platform, providing registered pharmacy professionals with enhanced access to patient medical information.

The new feature, now live on Cegedim Rx’s Pharmacy Services platform, allows community pharmacies to retrieve relevant medical data when delivering NHS clinical services.

Keep ReadingShow less